株探米国株
日本語 英語
エドガーで原本を確認する
0001000228 false NASDAQ 0001000228 2025-11-04 2025-11-04
 
 
 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
 
D.C. 20549
FORM
8-K
CURRENT REPORT
 
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 4, 2025
Henry Schein, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction
of incorporation)
 
0-27078
(Commission
File Number)
 
11-3136595
(IRS Employer
Identification No.)
 
 
 
 
 
135 Duryea Road
,
Melville
,
New York
(Address of principal executive offices)
11747
(Zip Code)
Registrant’s telephone number, including area code: (
631
)
843-5500
(Former name or former address, if changed since last
 
report.)
Check the appropriate box
 
below if the
 
Form 8-K filing is intended to simultaneously satisfy
 
the filing obligation of
 
the registrant under any
 
of the following
provisions:
 
Written communications pursuant
 
to Rule 425
 
under the Securities
 
Act (17 CFR 230.425)
 
Soliciting material pursuant to
 
Rule 14a-12 under
 
the Exchange Act (17
 
CFR 240.14a-12)
 
Pre-commencement communications pursuant to
 
Rule 14d-2(b) under
 
the Exchange Act
 
(17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to
 
Rule 13e-4(c) under the
 
Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to
 
Section 12(b) of the
 
Act:
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Common Stock, par value $.01 per share
 
HSIC
 
The
Nasdaq
 
Global Select Market
Indicate by check mark whether the registrant is an emerging growth
 
company as defined in Rule 405 of the Securities Act
 
of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2
 
of this chapter).
Emerging growth company
 
If an emerging growth company,
 
indicate by check mark if the registrant has
 
elected not to use the extended transition period
 
for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of
 
the Exchange Act.
 
 
Item 2.02.
 
Results of Operations and Financial Condition.
On November 4, 2025, Henry Schein, Inc. issued a press release
 
reporting the financial results for the three and
nine months, ended September 27, 2025.
 
The full text of the press release is attached hereto as Exhibit
 
99.1 and is
incorporated herein by reference.
The information in this Item 2.02 and the press release attached as Exhibit
 
99.1 are considered furnished to the
Securities and Exchange Commission and are not deemed filed for purposes
 
of Section 18 of the Securities Exchange
Act of 1934, as amended.
Item 9.01.
 
Financial Statements and Exhibits
(a)
 
Not applicable.
(b)
 
Not applicable.
(c)
 
Not applicable.
(d)
 
Exhibit 99.1 – Press Release dated November 4, 2025.
Exhibit 104 - Cover Page Interactive Data File (embedded within the
 
Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
 
registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
HENRY SCHEIN, INC.
By:
/s/ Ronald N. South
Ronald N. South
Senior Vice President and
Chief Financial Officer
(Authorized Signatory and Principal
Financial and Accounting Officer)
November 4, 2025
EXHIBIT INDEX
Exhibit No.
Description
104
Cover Page Interactive Data File (embedded within the Inline XBRL
 
document)
EX-99.1 2 exhibit991.htm EX-99.1 exhibit991
exhibit991p1i1 exhibit991p1i0
 
 
-1-
more
 
FOR IMMEDIATE RELEASE
HENRY SCHEIN REPORTS RECORD THIRD QUARTER 2025 FINANCIAL RESULTS AND RAISES
 
FULL YEAR NON-GAAP EPS GUIDANCE
Q3 2025 GAAP diluted EPS of $0.84,
 
compared to $0.78 GAAP diluted EPS in Q3 2024, and Q3 2025 non-
GAAP diluted EPS of $1.38,
 
compared to $1.22 non-GAAP diluted EPS in Q3 2024
Raises 2025 guidance for non-GAAP diluted EPS to $4.88 to $4.96 and sales
 
growth to 3-4% to reflect third
quarter results
Announces value creation initiatives expected to deliver over $200 million of
 
operating income improvement
over the next few years
Agreement reached to provide KKR the right to increase its HSIC stock ownership up to 19.9%
MELVILLE, N.Y.,
 
November 4, 2025 –
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health
care solutions to office-based dental and medical practitioners, today reported
 
financial results for the third quarter ended
September 27, 2025.
“We are pleased with our financial results for the third quarter, with sales growth accelerating in each of our
reportable segments including solid market share gains in our distribution
 
businesses as we are once again focused on driving
growth now that the cyber incident is fully behind us. This strong sales performance
 
was a key driver of the underlying
improvement in our operating income,” said Stanley M. Bergman, Chairman of the
 
Board and Chief Executive Officer of
Henry Schein. “Our successful execution of the BOLD+1 strategy, including the financial performance of our investments
 
in
high-growth, high-margin businesses,
 
set the foundation for strong future growth.”
 
“With continued input from KKR,
 
we have made good progress on advancing the value creation initiatives we
announced last quarter.
 
Based on our first phase of work, we believe we have
 
the opportunity
 
to deliver over $200 million of
improvements to operating income over the next few years,” Mr. Bergman said. “In addition, our board has approved an
amendment to the Strategic Partnership Agreement giving KKR the right to
 
increase its HSIC stock ownership up to 19.9%.”
Third Quarter 2025
 
Financial Results
Total
 
net sales
 
for the quarter were $3.3 billion.
 
As-reported total net sales increased 5.2% compared with the third
quarter of 2024 and reflects 3.3% internal sales growth, 0.7% sales growth
 
from acquisitions, and a 1.2% increase
resulting from foreign currency exchange.
 
Third-quarter sales growth is detailed in Exhibit A
1
.
Global Distribution and Value-Added Services sales
 
for the quarter increased 4.8%, and by 3.7% in constant
currencies compared with the third quarter of 2024. The main components
 
are:
 
 
 
 
 
 
 
 
-2-
more
Global Dental Distribution merchandise sales
 
for the quarter increased 4.6%, and by 2.9% in constant
currencies, compared with the third quarter of 2024, reflecting relatively
 
consistent sales growth in local
currencies across U.S. and international businesses.
Global Dental Distribution equipment sales
 
for the quarter increased 5.5%, and by 3.4% in constant
currencies, compared with the third quarter of 2024, driven by strong
 
growth in Germany,
 
as well as growth
in the U.S.
Global Medical Distribution sales
 
for the quarter increased 4.7%, and by 4.6% in constant currencies,
compared with the third quarter of 2024, reflecting good underlying growth
 
in medical products,
pharmaceuticals, and the Home Solutions business.
 
Global Value-added Services sales
for the
quarter increased
 
3.3%, and by 2.9%
 
in constant currencies,
compared with the third quarter of 2024,
 
with sales growth driven by consulting services.
Global Specialty Products sales
 
for the quarter increased 5.9%, and by 3.9%
 
in constant currencies,
 
compared with
the third quarter of 2024,
 
reflecting strong overall dental implant and endodontics sales growth.
Global Technology sales
 
for the quarter increased 9.7%, and by 9.0% in constant currencies, compared with
 
the
third quarter of 2024,
 
reflecting accelerated adoption of cloud-based software and sales
 
growth from recently
launched revenue cycle management solutions.
GAAP net income
2
 
for the quarter was $101 million, or $0.84 per diluted share
4
, and compares with third-quarter
2024 GAAP net income of $99 million, or $0.78 per diluted share.
Non-GAAP net income
2
for the quarter was $167 million, or $1.38
per diluted share
4
, and compares with third-
quarter 2024 non-GAAP net income of $155 million, or $1.22 per diluted
 
share.
 
Adjusted EBITDA
3
 
for the quarter was $295 million, and compares
 
with third-quarter 2024 Adjusted EBITDA of
$268 million.
The third quarter of 2025 includes a remeasurement gain which is $9 million
 
more than the remeasurement gain
recognized in the third quarter of 2024.
Year
 
-to-Date Financial Results
Total
 
net sales
 
for the first nine months of 2025 were $9.7 billion. As-reported
 
total net sales increased 2.8%
compared with the first nine months of 2024 and reflects 1.8%
 
internal sales growth, 0.9% sales growth from
acquisitions, and a 0.1% increase resulting from foreign currency exchange.
 
Sales growth is detailed in Exhibit A
1
.
GAAP net income
2
 
for the first nine months of 2025 was $297 million, or $2.42 per diluted share
4
, and compares
with the first nine months of 2024 GAAP net income of $296 million, or $2.30
 
per diluted share.
Non-GAAP net income
2
for the first nine months of 2025 was $445 million, or $3.63
per diluted share
4
, and
compares with the first nine months of 2024 non-GAAP net income
 
of $456 million, or $3.55 per diluted share.
 
Adjusted EBITDA
3
 
for the first nine months of 2025 was $810 million and compares with
 
first nine months of 2024
Adjusted EBITDA of $791 million.
 
 
-3-
more
Share Repurchases
During the third quarter of 2025, the Company repurchased
 
approximately 3.3 million shares of common stock at an
average price of $68.62 per share for a total of $229 million.
 
This included approximately 0.4 million shares of common stock to
 
complete its previously announced Accelerated
Stock Repurchase plan (ASR) at an average price of $71.60 per share,
 
for a total of $26.4 million. In addition, the Company
repurchased approximately 2.9 million shares of common stock at an average
 
price of $68.25 per share, for a total of $202.5
million. The net impact of share repurchases made in the quarter was
 
not material.
 
At the end of the third quarter, Henry Schein had $980 million authorized and available for
 
future stock repurchases.
 
Amendment to Strategic Partnership Agreement
The Company is also announcing today that its Board has approved an
 
amendment to the Strategic Partnership
Agreement giving KKR the right to increase its ownership in HSIC stock up to
 
19.9% through purchases in the open market.
2025 Financial Guidance
Henry Schein today raised its financial guidance for 2025. Guidance
 
is for current continuing operations as well as
acquisitions that have closed and does not include the impact of restructuring
 
expenses, amortization expense of acquired
intangible assets, the insurance claim recovery associated with the
 
cybersecurity incident, changes
 
in contingent
consideration, costs associated with shareholder advisory matters and select value
 
creation consulting costs,
 
and litigation
settlements.
 
This guidance also assumes that foreign currency exchange rates will
 
remain generally consistent with current
levels, that the effects of tariffs can be mitigated, and includes remeasurement gains related
 
to the purchase of controlling
interests of previously held non-controlling equity investments, consistent
 
with the Company’s business strategy.
 
2025 non-GAAP diluted EPS attributable to Henry Schein, Inc. is
 
raised to $4.88 to $4.96, previously $4.80 to $4.94,
reflecting year-over-year growth of 3% to 5%.
 
2025 total sales growth is raised to be approximately 3% to 4%
 
over 2024, previously 2% to 4% total sales growth.
2025 Adjusted EBITDA
3
 
growth is expected to increase mid-single digits compared with 2024, and remains
unchanged.
Adjustments to 2025 GAAP Net Income and Diluted EPS
The Company is providing guidance for 2025 diluted EPS on a non-GAAP
 
basis and for 2025 Adjusted EBITDA, as
noted above. The Company is not providing a reconciliation of its 2025 non-GAAP
 
diluted EPS guidance to its projected
2025 diluted EPS prepared on a GAAP basis, or its 2025
 
Adjusted EBITDA guidance to net income prepared on a GAAP
basis. This is because the Company is unable to provide without
 
unreasonable effort an estimate of restructuring costs related
to an ongoing initiative to drive operating efficiencies, including the corresponding tax
 
effect, which will be included in the
Company’s 2025 diluted EPS and net income, prepared on a GAAP basis. The inability to provide this reconciliation is due to the uncertainty and inherent difficulty of predicting the occurrence, magnitude, financial impact and timing of related
 
-4-
more
costs.
Management does not believe these items are representative of the Company’s underlying business performance.
 
For
the same reasons, the Company is unable to address the probable significance
 
of the unavailable information, which could be
material to future results.
Third-Quarter 2025 Conference Call Webcast
The Company will hold a conference call to discuss third-quarter 2025
 
financial results today, beginning at 8:00 a.m.
Eastern time. Individual investors are invited to listen to the
 
conference call through Henry Schein’s website by visiting
https://investor.henryschein.com/webcasts. In addition, a replay will be available beginning shortly after the call has
 
ended
for a period of one week.
 
The Company will be posting slides that provide a summary of its third-quarter
 
2025
 
financial results on its website
at https://www.henryschein.com/us-en/Corporate/investor-presentations.aspx.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care
 
professionals powered by a network of
people and technology. With more than 25,000 Team
 
Schein Members worldwide, the Company's network of trusted
advisors provides more than 1 million customers globally with more
 
than 300 valued solutions that help improve operational
success and clinical outcomes. Our Business, Clinical, Technology and Supply Chain solutions help office-based dental and
medical practitioners work more efficiently so they can provide quality care more
 
effectively. These solutions also support
dental laboratories, government and institutional health care clinics, as well
 
as other alternate care sites.
Henry Schein operates through a centralized and automated distribution
 
network, with a selection of more than
300,000 branded products and Henry Schein corporate brand products
 
in our main distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville,
N.Y.,
 
and has operations or affiliates in 33 countries and territories. The Company's sales reached
 
$12.7 billion in 2024, and
have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public
 
company in 1995.
For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein,
Instagram.com/HenrySchein,
 
and @HenrySchein on X.
Cautionary Note Regarding Forward-Looking Statements and Use
 
of Non-GAAP Financial Information
In accordance with the “Safe Harbor” provisions of the Private Securities Litigation
 
Reform Act of 1995, we provide the
following cautionary remarks regarding important factors that, among others,
 
could cause future results to differ materially from the
forward-looking statements, expectations and assumptions expressed or implied herein.
 
All forward-looking statements made by us are
subject to risks and uncertainties and are not guarantees of future performance.
 
These forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause our actual
 
results, performance and achievements or industry results to be
materially different from any future results, performance or achievements
 
expressed or implied by such forward-looking statements.
 
These statements include total sales growth, EPS and Adjusted EBITDA guidance
 
and are generally identified by the use of such
terms as “may,” “could,”
 
“expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,”
 
“to be,” “to make” or other
comparable terms. A fuller discussion of our operations, financial condition and status of litigation matters, including factors that may affect our business and future prospects, is contained in documents we have filed with the United States Securities and Exchange
 
 
 
-5-
more
Commission, or SEC, including our Annual Report on Form 10-K,
 
and will be contained in all subsequent periodic filings we make with
the SEC. These documents identify in detail important risk factors that could
 
cause our actual performance to differ materially from
current expectations.
Risk factors and uncertainties that could cause actual results to differ
 
materially from current and historical results include, but
are not limited to: our dependence on third parties for the manufacture and
 
supply of our products and where we manufacture products,
our dependence on third parties for raw materials or purchased components;
 
risks relating to the achievement of our strategic growth
objectives,
 
including anticipated results of restructuring and value creation initiatives; risks
 
related to the Strategic Partnership Agreement
with KKR Hawaii Aggregator L.P.
 
entered into in January 2025; transitions in senior company leadership; our
 
ability to develop or
acquire and maintain and protect new products (particularly technology
 
and specialty products) and services and utilize new technologies
that achieve market acceptance with acceptable margins; transitional
 
challenges associated with acquisitions and joint ventures, including
the failure to achieve anticipated synergies/benefits, as well as significant
 
demands on our operations, information systems, legal,
regulatory, compliance,
 
financial and human resources functions in connection with acquisitions, dispositions
 
and joint ventures; certain
provisions in our governing documents that may discourage third-party
 
acquisitions of us; adverse changes in supplier rebates or other
purchasing incentives; risks related to the sale of corporate brand products; risks related
 
to activist investors; security risks associated with
our information systems and technology products and services, such as cyberattacks
 
or other privacy or data security breaches (including
the October 2023 incident); effects of a highly competitive (including,
 
without limitation, competition from third-party online commerce
sites) and consolidating market; political, economic, and regulatory
 
influences on the health care industry; risks from expansion of
customer purchasing power and multi-tiered costing structures; increases in
 
shipping costs for our products or other service issues with
our third-party shippers, and increases in fuel and energy
 
costs; changes in laws and policies governing manufacturing, development
 
and
investment in territories and countries where we do business; general global and domestic
 
macro-economic and political conditions,
including inflation, deflation, recession, unemployment (and
 
corresponding increase in under-insured populations),
 
consumer confidence,
sovereign debt levels, fluctuations in energy pricing and
 
the value of the U.S. dollar as compared to foreign currencies and changes to
other economic indicators;
 
failure to comply with existing and future regulatory requirements, including
 
relating to health care; risks
associated with the EU Medical Device Regulation; failure to comply with
 
laws and regulations relating to health care fraud or other laws
and regulations; failure to comply with laws and regulations relating to the
 
collection, storage and processing of sensitive personal
information or standards in electronic health records or transmissions; changes
 
in tax legislation, changes in tax rates and availability of
certain tax deductions; risks related to product liability,
 
intellectual property and other claims; risks associated with customs policies or
legislative import restrictions; risks associated with disease outbreaks,
 
epidemics, pandemics (such as the COVID-19 pandemic), or
similar wide-spread public health concerns and other natural or man-made disasters; risks
 
associated with our global operations; the threat
or outbreak of war (including, without limitation, geopolitical wars),
 
terrorism or public unrest (including, without limitation, the war in
Ukraine, the Israel-Gaza war and other unrest and threats in the Middle East and
 
the possibility of a wider European or global conflict);
changes to laws and policies governing foreign trade, tariffs and
 
sanctions or greater restrictions on imports and exports, including
changes to international trade agreements and the current imposition of (and
 
the potential for additional) tariffs by the U.S. on numerous
countries and retaliatory tariffs; supply chain disruption;
 
litigation risks; new or unanticipated litigation developments and the status of
litigation matters; our dependence on our senior management, (including,
 
without limitation, succession planning for our Chief Executive
Officer), employee hiring and retention, increases in labor
 
costs or health care costs, and our relationships with customers, suppliers and
manufacturers; and disruptions in financial markets. The order in which
 
these factors appear should not be construed to indicate their
relative importance or priority.
We caution that
 
these factors may not be exhaustive and that many of these factors are beyond our
 
ability to control or predict.
Accordingly, any forward-looking
 
statements contained herein should not be relied upon as a prediction of actual
 
results. We undertake
no duty and have no obligation to update forward-looking statements except
 
as required by law.
 
Included within the press release are non-GAAP financial measures that supplement
 
the Company’s Consolidated Statements of
Income prepared under generally accepted accounting principles (GAAP).
 
These non-GAAP financial measures adjust the Company’s
actual results prepared under GAAP to exclude certain items. In the schedule
 
attached to the press release, the non-GAAP measures have
been reconciled to and should be considered together with the Consolidated
 
Statements of Income. Management believes that non-GAAP
financial measures provide investors with useful supplemental information
 
about the financial performance of our business, enable
comparison of financial results between periods where certain items may vary independent
 
of business performance and allow for greater
transparency with respect to key metrics used by management in operating
 
our business. The impact of certain items that are excluded
include integration and restructuring costs, amortization of acquisition-related
 
assets, the insurance claim recovery associated with the
cybersecurity incident, changes in contingent consideration, costs associated with shareholder
 
advisory matters and select value creation
consulting costs, and litigation settlements because the amount and
 
timing of such charges are significantly impacted by the timing, size,
number and nature of the acquisitions we consummate and occur on an
 
unpredictable basis. These non-GAAP financial measures are
presented solely for informational and comparative purposes and should
 
not be regarded as a replacement for corresponding, similarly
captioned, GAAP measures.
 
1
See Exhibit A for details of sales growth. Internal sales growth is calculated
 
from total net sales using constant foreign
currency exchange rates and excludes sales from acquisitions.
2
 
See Exhibit B for a reconciliation of GAAP net income and diluted
 
EPS to non-GAAP net income and diluted EPS.
 
 
 
 
 
 
 
-6-
more
3
See Exhibit C for a reconciliation of GAAP net income to Adjusted EBITDA.
4
 
References to diluted EPS refer to diluted EPS attributable to Henry Schein, Inc.
CONTACTS:
 
Investors
Ronald N. South
Senior Vice President and Chief Financial Officer
ronald.south@henryschein.com
(631) 843-5500
Graham Stanley
Vice President, Investor Relations and Strategic Financial Project Officer (in millions, except share and per share data)
graham.stanley@henryschein.com
(631) 843-5500
 
Media
Tim Vassilakos
Vice President,
 
Global Corporate Communications
timothy.vassilakos@henryschein.com
(516) 510-0926
(TABLES TO FOLLOW)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-7-
more
HENRY SCHEIN, INC.
CONDENSED CONSOLIDATED
 
STATEMENTS
 
OF INCOME
(unaudited)
Three Months Ended
Nine Months Ended
September 27,
September 28,
September 27,
September 28,
2025
2024
2025
2024
Net sales
 
$
3,339
$
3,174
$
9,747
$
9,482
Cost of sales
 
2,313
2,181
6,705
6,459
Gross profit
 
1,026
993
3,042
3,023
Operating expenses:
Selling, general and administrative
 
760
724
2,276
2,296
Depreciation and amortization
68
64
194
188
Restructuring costs
34
48
82
73
Operating income
164
157
490
466
Other income (expense):
Interest income
 
9
7
24
18
Interest expense
 
(38)
(34)
(111)
(96)
Other, net
 
(1)
(2)
(3)
(1)
Income before taxes, equity in earnings of affiliates and
noncontrolling interests
134
128
400
387
Income taxes
(28)
(32)
(94)
(97)
Equity in earnings of affiliates, net of tax
3
3
10
12
Net income
109
99
316
302
Less: Net income attributable to noncontrolling interests
 
(8)
-
(19)
(6)
Net income attributable to Henry Schein, Inc.
$
101
$
99
$
297
$
296
Earnings per share attributable to Henry Schein, Inc.:
Basic
 
$
0.84
$
0.79
$
2.44
$
2.32
Diluted
 
$
0.84
$
0.78
$
2.42
$
2.30
Weighted-average common
 
shares outstanding:
Basic
 
120,199,552
126,124,715
121,965,991
127,550,045
Diluted
 
121,036,247
127,054,934
122,840,062
128,498,494
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-8-
more
HENRY SCHEIN, INC.
CONDENSED CONSOLIDATED
 
BALANCE SHEETS
(in millions, except share data)
September 27,
December 28,
2025
2024
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents
 
$
136
$
122
Accounts receivable, net of allowance for credit losses of $84 and $78
1,743
1,482
Inventories, net
1,912
1,810
Prepaid expenses and other
 
604
569
Total current assets
 
4,395
3,983
Property and equipment, net
 
603
531
Operating lease right-of-use assets
308
293
Goodwill
 
4,147
3,887
Other intangibles, net
 
1,046
1,023
Investments and other
598
501
Total assets
 
$
11,097
$
10,218
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND
STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
 
$
1,035
$
962
Bank credit lines
 
913
650
Current maturities of long-term debt
 
30
56
Operating lease liabilities
81
75
Accrued expenses:
Payroll and related
 
291
303
Taxes
 
181
139
Other
 
618
618
Total current liabilities
 
3,149
2,803
Long-term debt
 
2,153
1,830
Deferred income taxes
 
144
102
Operating lease liabilities
264
259
Other liabilities
 
487
387
Total liabilities
 
6,197
5,381
Redeemable noncontrolling interests
 
877
806
Commitments and contingencies
 
Stockholders' equity:
Preferred stock, $0.01 par value, 1,000,000 shares authorized,
none outstanding
-
-
Common stock, $0.01 par value, 480,000,000 shares authorized,
118,567,917 issued and outstanding on September 27, 2025 and
124,155,884 issued and outstanding on December 28, 2024
1
1
Additional paid-in capital
207
-
Retained earnings
 
3,375
3,771
Accumulated other comprehensive loss
 
(222)
(379)
Total Henry Schein, Inc. stockholders' equity
3,361
3,393
Noncontrolling interests
662
638
Total stockholders' equity
 
4,023
4,031
Total liabilities, redeemable noncontrolling
 
interests and stockholders' equity
$
11,097
$
10,218
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-9-
more
HENRY SCHEIN, INC.
CONDENSED CONSOLIDATED
 
STATEMENTS
 
OF CASH FLOWS
(in millions)/(unaudited)
Three Months Ended
Nine Months Ended
September 27,
September 28,
September 27,
September 28,
2025
2024
2025
2024
Cash flows from operating activities:
Net income
$
109
$
99
$
316
$
302
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
 
80
74
229
221
Impairment charge on intangible assets
-
-
1
-
Non-cash restructuring charges
4
5
7
11
Stock-based compensation expense
13
10
29
30
Provision for losses on trade and other accounts receivable
 
4
5
9
12
Provision for (benefit from) deferred income taxes
7
(22)
-
(41)
Equity in earnings of affiliates
(3)
(3)
(10)
(12)
Distributions from equity affiliates
 
1
1
9
10
Changes in unrecognized tax benefits
7
-
6
3
Other
 
(13)
(16)
(44)
(25)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable
 
(98)
(82)
(198)
188
Inventories
 
4
(69)
(25)
38
Other current assets
 
(40)
(12)
(3)
38
Accounts payable and accrued expenses
 
99
161
5
(131)
Net cash provided by operating activities
174
151
331
644
Cash flows from investing activities:
Purchases of property and equipment
(33)
(34)
(96)
(112)
Payments related to equity investments and business acquisitions,
net of cash acquired
 
(11)
(42)
(112)
(223)
Proceeds from loan to affiliate
-
-
2
3
Capitalized software costs
(12)
(10)
(38)
(30)
Other
 
-
(5)
(9)
(10)
Net cash used in investing activities
 
(56)
(91)
(253)
(372)
Cash flows from financing activities:
Net change in bank credit lines
9
132
257
374
Proceeds from issuance of long-term debt
 
70
30
314
120
Principal payments for long-term debt
 
(7)
(16)
(28)
(193)
Debt issuance costs
-
-
(2)
-
Proceeds from issuance of stock upon exercise of stock options
 
-
1
1
3
Payments for repurchases and retirement of common stock
 
(203)
(135)
(650)
(310)
Issuance of common stock
-
-
250
-
Payments for taxes related to shares withheld for employee taxes
-
(1)
(14)
(9)
Proceeds from (distributions to) noncontrolling shareholders
6
(8)
(12)
(36)
Payments for contingent consideration
-
-
(19)
-
Acquisitions of noncontrolling interests in subsidiaries
 
(2)
(44)
(79)
(255)
Net cash provided by (used in) financing activities
(127)
(41)
18
(306)
Effect of exchange rate changes on cash and cash equivalents
-
(31)
(82)
(11)
Net change in cash and cash equivalents
(9)
(12)
14
(45)
Cash and cash equivalents, beginning of period
 
145
138
122
171
Cash and cash equivalents, end of period Exhibit A - Third Quarter Sales
$
136
$
126
$
136
$
126
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-10-
more
Henry Schein, Inc.
2025 Third Quarter
Sales Summary
(in millions)
(unaudited)
Q3 2025 over Q3 2024
Constant Currency Growth
Q3 2025
Q3 2024
Local Internal
Growth
Acquisition
Growth
Total
Constant
Currency
Growth
Foreign
Exchange
Impact
Total Sales
Growth
U.S. Distribution and Value-Added Services
Merchandise
$
607
$
587
3.3%
0.0%
3.3%
0.0%
3.3%
Equipment
217
215
1.2%
0.0%
1.2%
0.0%
1.2%
Value-Added Services
57
56
0.9%
0.9%
1.8%
0.0%
1.8%
Total Dental
881
858
2.6%
0.1%
2.7%
0.0%
2.7%
Medical
1,099
1,050
3.0%
1.7%
4.7%
0.0%
4.7%
Total U.S. Distribution and Value-Added Services
1,980
1,908
2.9%
0.9%
3.8%
0.0%
3.8%
International Distribution and Value-Added Services
Merchandise
603
568
2.4%
0.1%
2.5%
3.5%
6.0%
Equipment
223
202
5.1%
0.6%
5.7%
4.4%
10.1%
Value-Added Services
7
7
-0.4%
11.7%
11.3%
4.0%
15.3%
Total Dental
833
777
3.0%
0.4%
3.4%
3.8%
7.2%
Medical
27
26
2.5%
0.0%
2.5%
3.2%
5.7%
Total International Distribution and Value-Added Services
860
803
3.0%
0.4%
3.4%
3.7%
7.1%
Global Distribution and Value-Added Services
Global Merchandise
1,210
1,155
2.8%
0.1%
2.9%
1.7%
4.6%
Global Equipment
440
417
3.0%
0.4%
3.4%
2.1%
5.5%
Global Value-Added Services
64
63
0.7%
2.2%
2.9%
0.4%
3.3%
Global Dental
1,714
1,635
2.8%
0.2%
3.0%
1.8%
4.8%
Global Medical
1,126
1,076
3.0%
1.6%
4.6%
0.1%
4.7%
Total Global Distribution and Value-Added Services
2,840
2,711
2.9%
0.8%
3.7%
1.1%
4.8%
Global Specialty Products
369
348
2.8%
1.1%
3.9%
2.0%
5.9%
Global Technology
173
157
9.0%
0.0%
9.0%
0.7%
9.7%
Eliminations
(43)
(42)
n/a
n/a
n/a
n/a
n/a
Total Global
$
3,339
$
3,174
3.3%
0.7%
4.0%
1.2%
5.2%
Note: Prior period amounts have been reclassified to conform
 
to the current period presentation.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-11-
more
Exhibit A - Year-to-Date Sales
Henry Schein, Inc.
2025 Third Quarter Year-to-Date
Sales Summary
(in millions)
(unaudited)
Q3 2025 Year-to-Date over Q3 2024 Year-to-Date
Constant Currency Growth
Q3 2025
Q3 2024
Local Internal
Growth
Acquisition
Growth
Total
Constant
Currency
Growth
Foreign
Exchange
Impact
Total Sales
Growth
U.S. Distribution and Value-Added Services
Merchandise
$
1,800
$
1,788
0.6%
0.0%
0.6%
0.0%
0.6%
Equipment
623
650
-4.1%
0.0%
-4.1%
0.0%
-4.1%
Value-Added Services
153
159
-5.5%
1.4%
-4.1%
0.0%
-4.1%
Total Dental
2,576
2,597
-0.9%
0.0%
-0.9%
0.0%
-0.9%
Medical
3,117
2,978
3.2%
1.5%
4.7%
0.0%
4.7%
Total U.S. Distribution and Value-Added Services
5,693
5,575
1.3%
0.8%
2.1%
0.0%
2.1%
International Distribution and Value-Added Services
Merchandise
1,813
1,791
0.7%
0.6%
1.3%
-0.1%
1.2%
Equipment
640
595
5.0%
1.4%
6.4%
1.1%
7.5%
Value-Added Services
21
16
-0.1%
40.2%
40.1%
-1.8%
38.3%
Total Dental
2,474
2,402
1.8%
1.0%
2.8%
0.2%
3.0%
Medical
80
81
-1.7%
0.0%
-1.7%
0.5%
-1.2%
Total International Distribution and Value-Added Services
2,554
2,483
1.6%
1.1%
2.7%
0.2%
2.9%
Global Distribution and Value-Added Services
Global Merchandise
3,613
3,579
0.6%
0.4%
1.0%
-0.1%
0.9%
Global Equipment
1,263
1,245
0.3%
0.6%
0.9%
0.5%
1.4%
Global Value-Added Services
174
175
-5.0%
4.9%
-0.1%
-0.2%
-0.3%
Global Dental
5,050
4,999
0.4%
0.5%
0.9%
0.1%
1.0%
Global Medical
3,197
3,059
3.0%
1.5%
4.5%
0.0%
4.5%
Total Global Distribution and Value-Added Services
8,247
8,058
1.4%
0.9%
2.3%
0.1%
2.4%
Global Specialty Products
1,122
1,078
2.3%
1.5%
3.8%
0.2%
4.0%
Global Technology
502
470
6.3%
0.0%
6.3%
0.4%
6.7%
Eliminations
(124)
(124)
n/a
n/a
n/a
n/a
n/a
Total Global
$
9,747
$
9,482
1.8%
0.9%
2.7%
0.1%
2.8%
Note: Prior period amounts have been reclassified to conform
 
to the current period presentation.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-12-
more
Exhibit B
Henry Schein, Inc.
2025 Third Quarter and Year-to-Date
Reconciliation of reported GAAP net income and diluted EPS attributable to
 
Henry Schein, Inc.
to non-GAAP net income and diluted EPS attributable to Henry Schein,
 
Inc.
(in millions, except per share data)
(unaudited)
Third Quarter
Year
 
-to-Date
%
%
2025
2024
Growth
2025
2024
Growth
Net income attributable to Henry Schein, Inc.
$
101
$
99
2.0
%
$
297
$
296
0.4
%
Diluted EPS attributable to Henry Schein, Inc.
$
0.84
$
0.78
7.7
%
$
2.42
$
2.30
5.2
%
Non-GAAP Adjustments, net of tax and attribution to
noncontrolling interests
Restructuring costs (1)
$
25
$
33
$
58
$
51
Acquisition intangible amortization (2)
27
29
81
85
Cyber incident-insurance proceeds, net of third-party advisory
expenses (3)
-
(6)
(15)
(8)
Change in contingent consideration (4)
5
-
3
28
Costs associated with shareholder advisory matters and select
value creation consulting costs (5)
7
-
18
-
Litigation settlements (6)
1
-
2
4
Impairment of intangible assets (7)
-
-
1
-
Non-GAAP adjustments to net income
$
65
$
56
$
148
$
160
Non-GAAP adjustments to diluted EPS
 
0.54
0.43
1.21
1.24
Non-GAAP net income attributable to Henry Schein, Inc.
$
167
$
155
8.3
%
$
445
$
456
(2.3)
%
Non-GAAP diluted EPS attributable to Henry Schein, Inc.
$
1.38
$
1.22
13.1
%
$
3.63
$
3.55
2.3
%
Management believes that non-GAAP financial measures
 
provide investors with useful supplemental information
 
about the financial
performance of our business, enable comparison of financial results
 
between periods where certain items may
 
vary independent of
business performance and allow for greater transparency
 
with respect to key metrics used by management
 
in operating our business.
These non-GAAP financial measures are
 
presented solely for informational and comparative
 
purposes and should not be regarded
 
as a
replacement for corresponding,
 
similarly captioned, GAAP measures.
 
Net income growth rates are
 
based on actual values and may not
recalculate due to rounding.
 
Amounts may not sum due to rounding.
(1)
 
Restructuring Costs
The following table presents details of our restructuring costs:
Third Quarter
Year
 
-to-Date
2025
2024
2025
2024
Restructuring costs - pre-tax, as reported
$
34
$
48
$
82
73
Income tax benefit
(9)
(12)
(21)
(18)
Amount attributable to noncontrolling interests
-
(3)
(3)
(4)
Restructuring costs, net
$
25
$
33
$
58
$
51
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-13-
more
(2)
 
Acquisition Intangible Amortization
The following table presents details of amortization of acquired intangible
 
assets:
Third Quarter
Year
 
-to-Date
2025
2024
2025
2024
Acquisition intangible amortization - pre-tax, as reported
$
46
$
47
$
133
140
Income tax benefit
(12)
(12)
(33)
(35)
Amount attributable to noncontrolling interests
(7)
(6)
(19)
(20)
Acquisition intangible amortization, net
$
27
$
29
$
81
$
85
(3)
 
Represents cyber insurance proceeds, net of one time professional and
 
other fees related to remediation of our Q4
2023 cyber incident.
 
During Q1 2025, we received insurance proceeds of $20 million ($15 million,
 
net of taxes)
under this policy representing the remaining insurance recovery
 
of losses related to the cyber incident.
 
During Q3
2024 and YTD 2024, we received insurance proceeds of $10 million ($7
 
million, net of taxes) and $20 million ($15
million, net of taxes), respectively,
 
representing a partial insurance recovery of losses related to the cyber incident.
 
One time professional and other fees were $1 million ($1 million, net of taxes) and $9 million
 
($7 million, net of
taxes), for Q3 2024 and YTD 2024, respectively.
(4)
 
Represents a change in the fair value of contingent consideration of $7 million ($5
 
million, net of taxes) and $5
million ($3 million, net of taxes) recorded during Q3 2025 and YTD 2025,
 
respectively, related to acquisitions
 
and
$38 million ($28 million, net of taxes) recorded during YTD 2024, respectively,
 
related to a 2023 acquisition.
(5)
 
Represents costs associated with shareholder advisory matters and select value
 
creation consulting costs of $10
million ($7 million, net of taxes) and $24 million ($18 million, net of
 
taxes) recorded during Q3 2025 and YTD
2025, respectively.
(6)
 
Represents settlement amounts for litigation related to certain opioid related
 
lawsuits during Q3 2025 and YTD 2025
and a settlement at one of our businesses.
 
Represents YTD 2024 settlement amounts for litigation related to the
October 2023 cyber incident and settlement of certain opioid related lawsuits.
(7)
 
Represents impairment charges recorded in Q1 2025 on
 
certain intangible assets.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-14-
###
Exhibit C
Henry Schein, Inc.
2025 Third Quarter and Year
 
-to-Date
Reconciliation of reported GAAP net income to Adjusted EBITDA
(in millions)
(unaudited)
Third Quarter
Year-to-Date
2025
2024
2025
2024
Net income attributable to Henry Schein, Inc. (GAAP)
$
101
$
99
$
297
296
Income attributable to noncontrolling interests
8
-
19
6
Net income (GAAP)
109
99
316
302
Definitional adjustments:
Interest income
(9)
(7)
(24)
(18)
Interest expense
38
34
111
96
Income taxes
28
32
94
97
Depreciation and amortization
80
74
229
221
Non-GAAP adjustments:
Restructuring costs
34
48
82
73
Cyber incident-insurance proceeds, net of third-party advisory
 
expenses
-
(9)
(20)
(11)
Impairment of intangible assets
-
-
1
-
Change in contingent consideration
6
-
4
38
Costs associated with shareholder advisory matters and select
 
value creation consulting costs
10
-
24
-
Litigation settlements
2
-
3
5
Other adjustments:
Equity in earnings of affiliates, net of tax
(3)
(3)
(10)
(12)
Adjusted EBITDA (non-GAAP)
$
295
$
268
$
810
$
791
Adjusted EBITDA is a non-GAAP measure that we calculate
 
in the manner reflected on Exhibit C. We define Adjusted EBITDA as net income, excluding
 
(i) net
income attributable to noncontrolling interests, (ii) interest income
 
and expense, (iii) income taxes, (iv) depreciation and amortization,
 
(v) restructuring costs, (vi)
cyber incident-insurance proceeds, net of third-party advisory
 
expenses, (vii) impairment of intangible assets, (viii)
 
change in contingent consideration, (ix) costs
associated with shareholder advisory matters and select value creation
 
consulting costs, (x) litigation settlements and (xi)
 
equity in earnings of affiliates, net of tax.
 
Amounts may not sum due to rounding.